% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • atlnsider atlnsider Mar 4, 2011 5:38 PM Flag

    vivus just released pr stating

    “The change in pregnancy category for topiramate does not impact the Qnexa regulatory strategy,” said Susan Brophy, an outside spokeswoman for Vivus, in an e-mailed statement today. “We expect to reach agreement with the FDA, and if deemed feasible, initiate the retrospective observational study on fetal outcomes within the next two months.”

1.100.00(0.00%)Jun 24 4:00 PMEDT